Mahmood Syed Asaad, Zafar Shakir, Shakir Munira, Rizvi Syed Fawad
Department of Ophthalmology, LRBT Free Base Eye Hospital, Karachi.
J Coll Physicians Surg Pak. 2014 Dec;24(12):922-6.
To determine the changes in visual acuity in patients undergoing Trans-Scleral Sutured Posterior Chamber Intra-Ocular Lens (TSSPCIOL) implantation at a tertiary care hospital in Karachi, Pakistan.
Case series.
LRBT Tertiary Eye Hospital, Karachi, from January 2006 to December 2010.
Records of all patients undergoing implantation of TSSPCIOL were reviewed. Patients with diagnosed glaucoma, diabetic retinopathy, macular degeneration, history of recurrent uveitis, corneal haze or central corneal scars were excluded. For the final analysis, 70 eyes out of a total of 75 were selected. Main outcomes of interest were pre and postoperative visual acuities and surgical complications. SPSS 21 was used for data analysis.
Pre-operatively, the average Best Spectacle-Corrected Visual Acuity (BSCVA) was 6/36 on the Snellen chart. This improved to 6/12 postoperatively. The mean improvement seen was 2.4 lines on the Snellen chart (p < 0.05). Complications include transient intraocular pressure elevation in 25 eyes (36%), IOL tilt in 4 eyes (7.1%), Cystoid Macular Edema (CME) in 4 eyes (5.7%), vitreous haemorrhage in 2 eyes (2.9%), hyphema in 2 eyes (2.9%), uveitis in 1 eye (1.4%), and retinal detachment 1 eye (1.4%). No IOL subluxation, suture erosion, iris capture, choroidal effusion or endophthalmitis was encountered and no re-operations were needed.
TSSPCIOLs are a good management option for patients with aphakia in whom PC IOLs cannot be placed.
确定在巴基斯坦卡拉奇一家三级护理医院接受经巩膜缝合后房型人工晶状体(TSSPCIOL)植入术患者的视力变化。
病例系列。
2006年1月至2010年12月,卡拉奇LRBT三级眼科医院。
回顾所有接受TSSPCIOL植入术患者的记录。排除诊断为青光眼、糖尿病性视网膜病变、黄斑变性、复发性葡萄膜炎病史、角膜混浊或中央角膜瘢痕的患者。最终分析时,从总共75只眼中选取了70只眼。主要关注的结果是术前和术后视力以及手术并发症。使用SPSS 21进行数据分析。
术前,Snellen视力表上的平均最佳矫正视力(BSCVA)为6/36。术后提高到6/12。Snellen视力表上平均提高了2.4行(p<0.05)。并发症包括25只眼(36%)出现短暂性眼压升高,4只眼(7.1%)出现人工晶状体倾斜,4只眼(5.7%)出现黄斑囊样水肿(CME),2只眼(2.9%)出现玻璃体积血,2只眼(2.9%)出现前房积血,1只眼(1.4%)出现葡萄膜炎,1只眼(1.4%)出现视网膜脱离。未遇到人工晶状体半脱位、缝线侵蚀、虹膜夹持、脉络膜渗漏或眼内炎,也无需再次手术。
对于无法植入后房型人工晶状体的无晶状体患者,TSSPCIOL是一种良好的治疗选择。